MedAware vs TheraDoc (2026)
A learned model against a rules engine, in the same pharmacy department. TheraDoc watches live laboratory, microbiology, pharmacy and admission feeds and raises alerts for stewardship, infection prevention and anticoagulation from rules the hospital's own staff write and can read. Its one learned component is the InsightRX Nova dosing model it integrates. MedAware detects prescriptions that do not fit the patient, using outlier detection over longitudinal data. These are layers rather than alternatives. Rules catch the known hazard, and they generate most of the alert volume. The outlier model catches what no rule anticipated. The diligence questions differ: how TheraDoc's rules are validated and retired, and how MedAware's model performs across the populations you treat.
- It detects prescribing outliers a rule library cannot express, using outlier detection over longitudinal patient data rather than pairwise checks.
- Hospital investigators at four sites have published on it, two of them with alerts firing live.
- It runs natively inside an Epic pharmacy workflow at Ballad Health and is listed in the athenahealth Marketplace.
- One platform covers infection prevention with mandatory reporting, antimicrobial stewardship, pharmacy surveillance and anticoagulation.
- Premier states business associate status for the protected health information it receives, where MedAware states no HIPAA status.
- Alerts route to a clinical pharmacist or infection preventionist who investigates, and the platform never touches an order.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MedAware and TheraDoc are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | MedAware | TheraDoc |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Founded | 2012 | 1999 |
| Headquarters | Ra'anana, Israel | Salt Lake City, Utah, United States |
| Website | medaware.com | solutions.premierinc.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
MedAware is an Israeli company whose platform monitors prescribing for medication related risk using machine learning rather than the rule libraries that conventional medication decision support runs on. It was founded in 2012 after a nine year old asthma patient died because his physician selected the wrong drug from an electronic prescribing dropdown, an error no interaction rule was written to catch, because nothing in the prescription broke a rule; the drug was simply wrong for that patient.
Source: AI Health Index, September 2026
TheraDoc is a hospital clinical surveillance platform. It was founded in Salt Lake City in 1999, sold to Hospira, and acquired by Premier in 2014 for $117 million in cash, and is now marketed as Premier's Clinical Surveillance powered by TheraDoc, for acute and post acute settings.
Source: AI Health Index, September 2026
Questions buyers ask
How are MedAware and TheraDoc priced and sold?
MedAware publishes no price, no unit, no pricing mechanism, no contract shape and no implementation fee guidance. It sells directly to health systems and to physician practices through the athenahealth Marketplace, but nothing says what drives the cost on either route.
With TheraDoc, two commercial dynamics bear on renewal. The parent completed a take private transaction valued at $2.6 billion after reporting an eleven percent revenue decline in fiscal 2025, and private equity ownership typically brings a review of product pricing and portfolio scope, so renewal terms may not carry over unchanged. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
How much do MedAware and TheraDoc leave to the clinician?
In MedAware's case, two published numbers make the oversight picture legible: an alert burden of roughly 1.6 percent of medical orders, and a prescriber behavior change rate the company puts above 40 percent.
For TheraDoc, the structural difference from a model driven product is that the customer authors the logic: alert rules are written by the hospital's own clinicians rather than supplied by the vendor, so the institution controls both what fires and what threshold fires it, and there is no vendor decision to defer to. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
One engine evaluates rules the hospital's own staff wrote and the other learns what normal looks like, so the questions differ. For the surveillance platform, ask for the rule validation method and how often rules are retired. For the outlier model, ask for performance by patient group, since what counts as anomalous depends on the population the model learned from. MedAware publishes no results by age, sex, race, ethnicity, insurance status or site.
It also publishes no security attestation and states no HIPAA status. TheraDoc names an ONC Health IT certification, which tests software features rather than how Premier operates security. Neither publishes a price.